Frontlight ResearchEarly access
Trial site
Rakuwakai Otowa Hospital
- 5running trials
- 3closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Obesity3 trials
- Heart failure2 trials
- Atopic dermatitis (eczema)1 trial
- Atrial fibrillation1 trial
- Diabetic eye disease1 trial
- Macular degeneration1 trial
- Stroke1 trial
- Phase
- Phase 35 trials
- Phase 23 trials
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Amgen3 trials
- Eli Lilly and Company2 trials
- Kyowa Kirin Co., Ltd.2 trials
- Regeneron Pharmaceuticals1 trial
Running trials
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Active, not recruiting
Recruiting
Active, not recruiting
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation1 recruiting
- Heart failure1 recruiting
- Obesity1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Terminated
Completed
A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)
Site data: ClinicalTrials.govUpdated 19 Nov 2026